Sanjivani Paranteral Ltd.
BSE: 531569
₹143.70
₹-4.35
(-2.94%)
As on 03-Jun-2026IST
Market cap
₹177 Cr
Revenue (TTM)
₹69 Cr
P/E Ratio
26
P/B Ratio
3.7
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹7 Cr
-
ROE
25.9 %
-
ROCE
29.2 %
-
Industry P/E
33.52
-
EV/EBITDA
16.6
-
Debt to Equity
0.2
-
Book Value
₹39.3
-
EPS
₹5.6
-
Face value
10
-
Shares outstanding
12,284,300
10 Years Aggregate
CFO
₹30.85 Cr
EBITDA
₹-53.39 Cr
Net Profit
₹-72.66 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Sanjivani Pa
| -37.9 | -10.2 | -23.1 | -41.8 | 29.5 | 66.6 | 17.5 |
|
BSE Healthcare
| 7.1 | 4.2 | 6.3 | 9.1 | 24.6 | 13.5 | 11.9 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
|---|---|---|---|---|---|
|
Sanjivani Pa
| -39.3 | 111.5 | 363.0 | 3.5 | 263.0 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Sanjivani Pa
|
143.7 | 176.5 | 68.7 | 6.7 | 13.2 | 14.6 | 26 | 3.7 |
| 2,929.2 | 36,613.0 | 5,452.9 | 1,056.0 | 22.4 | 23.9 | 34.7 | 8.1 | |
| 8,557.0 | 21,370.8 | 2,275.6 | 187.5 | 10.3 | 22.9 | 114 | 24.5 | |
| 1,972.9 | 15,008.9 | 2,187.2 | 649.7 | 31.5 | 19 | 23.4 | 4.2 | |
| 1,703.0 | 10,378.0 | 1,196.4 | 149.4 | -- | 27.5 | 56.1 | 13.9 | |
| 1,397.1 | 19,342.6 | 3,129.4 | 647.4 | 26.9 | 18.1 | 31.2 | 5.0 | |
| 2,140.0 | 34,351.5 | 4,147.8 | 709.5 | 22.3 | 19.1 | 48.4 | 8.3 | |
| 4,465.5 | 20,444.0 | 2,519.7 | 722.4 | 33.6 | 18.8 | 28.3 | 4.9 | |
| 6,108.5 | 10,147.3 | 1,408.0 | 326.9 | 30.8 | 57.1 | 31 | 19.3 | |
| 1,081.2 | 9,962.0 | 4,858.7 | 574.1 | 14.9 | 19.7 | 17.9 | 3.2 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Sanjivani Pa
Manufacture of allopathic pharmaceutical preparations
-
Incorporated
1994
-
Chairman
Ashwani Khemka
-
Managing Director
Ashwani Khemka
-
Headquarters
Mumbai, Maharashtra
-
Website
Looking for more details about Sanjivani Paranteral Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
FAQs for Sanjivani Pa
What is the current share price of Sanjivani Paranteral Ltd Today?
The share price of Sanjivani Paranteral Ltd is ₹143.70 (BSE) as of 03-Jun-2026 IST. Sanjivani Paranteral Ltd has given a return of 29.45% in the last 3 years.
What is the current PB & PE ratio of Sanjivani Paranteral Ltd?
The P/E ratio of Sanjivani Paranteral Ltd is 26.01 times as on 03-Jun-2026, a 22 discount to its peers’ median range of 33.52 times.
The P/B ratio of Sanjivani Paranteral Ltd is 3.66 times as on 03-Jun-2026, a 20 discount to its peers’ median range of 4.58 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
35.17
|
7.77
|
|
2024
|
28.44
|
6.78
|
|
2023
|
9.18
|
-13.49
|
|
2022
|
13.51
|
-8.64
|
|
2021
|
6.59
|
-0.21
|
What is the 52 Week High and Low of Sanjivani Paranteral Ltd?
The 52-week high and low of Sanjivani Paranteral Ltd are Rs 268.80 and Rs 126.00 as of 03-Jun-2026.
What is the market cap of Sanjivani Paranteral Ltd?
Sanjivani Paranteral Ltd has a market capitalisation of ₹ 177 Cr as on 03-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Sanjivani Paranteral Ltd?
Before investing in Sanjivani Paranteral Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.